• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

1,093
79
60
57
47

COUNTRY

55
17
8
6
5

CATEGORIES

  • 82
  • 121
  • 66
  • 66
  • 36
  • 37
  • 12
  • 11
  • 12
  • 18

PRICE

546
810
1,773
2,600

PUBLISHED

214
314
747
2,600

PRODUCT TYPE

2,454
71
62
12
1

Oncology

The American Cancer Society forecasts that 1,638,910 new cancer cases will occur in the United States in 2012. As cancer rates worldwide are increasing, the oncological sector of the pharmaceutical industry is growing fast and it will continue to provide business opportunities in the next years. However, cancer trials are some of the most complex, time consuming and expensive across all therapeutic areas. What are the new paths to success in this lucrative but challenging market?

Find out the answer in the reports, books, and subscriptions listed under Research and Markets’ Oncology category. Our top-quality publications from industry experts cover every aspect of cancer drug therapy, with a focus on: Lung Cancer, Breast Cancer, Prostate Cancer, Leukaemia, Lymphoma, Ovarian Cancer, Colon Cancer, Cervical Cancer, Brain Cancer and Bladder Cancer. So read on for the latest clinical trials, pipeline reviews, industry news, and commercial opportunities.

Key players featured in our publications include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis, Wyeth, and many more. Show Less
Read more

PRODUCT TITLE

Neuroendocrine Cancer Global Clinical Trials Review, H1, 2014

Neuroendocrine Cancer Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Neuroendocrine Cancer Global Clinical Trials Review, H1, 2014" provides data on the Neuroendocrine...

March 2014
FROM

Low-Grade Glioma Global Clinical Trials Review, H1, 2014

Low-Grade Glioma Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Low-Grade Glioma Global Clinical Trials Review, H1, 2014" provides data on the Low-Grade Glioma clinical...

March 2014
FROM

Malignant Glioma Global Clinical Trials Review, H1, 2014

Malignant Glioma Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Malignant Glioma Global Clinical Trials Review, H1, 2014" provides data on the Malignant Glioma clinical...

March 2014
FROM

Pontine Glioma Global Clinical Trials Review, H1, 2014

Pontine Glioma Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Pontine Glioma Global Clinical Trials Review, H1, 2014" provides data on the Pontine Glioma clinical trial...

March 2014
FROM

Breast Cancer - Pipeline Review, H1 2014

Breast Cancer - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Breast Cancer - Pipeline Review, H1 2014’, provides an overview of the Breast Cancer’s therapeutic pipeline. This report...

March 2014
FROM

Relapsed Multiple Myeloma - Pipeline Review, H1 2014

Relapsed Multiple Myeloma - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Relapsed Multiple Myeloma - Pipeline Review, H1 2014’, provides an overview of the Relapsed Multiple Myeloma’s...

March 2014
FROM

Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H1 2014

Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review,...

March 2014
FROM

Multiple Myeloma (Kahler's Disease) - Pipeline Review, H1 2014

Multiple Myeloma (Kahler's Disease) - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Multiple Myeloma (Kahler's Disease) - Pipeline Review, H1 2014’, provides an overview of the Multiple...

March 2014
FROM

Chemotherapy Induced Anemia - Pipeline Review, H1 2014

Chemotherapy Induced Anemia - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Chemotherapy Induced Anemia - Pipeline Review, H1 2014’, provides an overview of the Chemotherapy Induced Anemia’s...

March 2014
FROM

Meningioma Global Clinical Trials Review, H1, 2014

Meningioma Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Meningioma Global Clinical Trials Review, H1, 2014" provides data on the Meningioma clinical trial scenario....

March 2014
FROM

Chemotherapy Induced Pain Global Clinical Trials Review, H1, 2014

Chemotherapy Induced Pain Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Chemotherapy Induced Pain Global Clinical Trials Review, H1, 2014" provides data on the Chemotherapy...

March 2014
FROM

Neuroblastoma Global Clinical Trials Review, H1, 2014

Neuroblastoma Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Neuroblastoma Global Clinical Trials Review, H1, 2014" provides data on the Neuroblastoma clinical trial scenario....

March 2014
FROM

Cholangiocellular Hepatoma Global Clinical Trials Review, H1, 2014

Cholangiocellular Hepatoma Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Cholangiocellular Hepatoma Global Clinical Trials Review, H1, 2014" provides data on the Cholangiocellular...

March 2014
FROM

Hormone-Sensitive Prostate Cancer Global Clinical Trials Review, H1, 2014

Hormone-Sensitive Prostate Cancer Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Hormone-Sensitive Prostate Cancer Global Clinical Trials Review, H1, 2014" provides data...

March 2014
FROM

Germinomatous (Seminomatous) Germ Cell Tumors Global Clinical Trials Review, H1, 2014

Germinomatous (Seminomatous) Germ Cell Tumors Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Germinomatous (Seminomatous) Germ Cell Tumors Global Clinical Trials Review,...

March 2014
FROM

Penile Cancer Global Clinical Trials Review, H1, 2014

Penile Cancer Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Penile Cancer Global Clinical Trials Review, H1, 2014" provides data on the Penile Cancer clinical trial scenario....

March 2014
FROM

Gastroesophageal (GE) Junction Carcinomas Global Clinical Trials Review, H1, 2014

Gastroesophageal (GE) Junction Carcinomas Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Gastroesophageal (GE) Junction Carcinomas Global Clinical Trials Review, H1, 2014"...

March 2014
FROM

Malignant Mesothelioma Global Clinical Trials Review, H1, 2014

Malignant Mesothelioma Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Malignant Mesothelioma Global Clinical Trials Review, H1, 2014" provides data on the Malignant Mesothelioma...

March 2014
FROM

Nasopharyngeal Cancer Global Clinical Trials Review, H1, 2014

Nasopharyngeal Cancer Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Nasopharyngeal Cancer Global Clinical Trials Review, H1, 2014" provides data on the Nasopharyngeal...

March 2014
FROM

OpportunityAnalyzer: Pancreatic Cancer - Opportunity Analysis and Forecasts to 2017

OpportunityAnalyzer: Pancreatic Cancer - Opportunity Analysis and Forecasts to 2017 Summary With five-year survival only approximately 5%, pancreatic cancer is characterized as a disease with some...

March 2014
FROM
Loading Indicator

Our Clients

Photocure ASA Roche Diagnostics Ltd. Abbott Laboratories Ltd. Pfizer, Inc. Novartis AG Becton, Dickinson and Company (BD)